Management Committee
Chair of the Action:
Dr Peyman GHAFFARI (Portugal)
Vice Chair of the Action:
Prof Ana Marija GRANCARIC (Croatia)
Science officer of the Action:
Administrative officer of the Action:
MC Members and Substitutes
Country | MC Member |
---|---|
Belgium | Prof Paul KIEKENS |
Bosnia and Herzegovina | Dr Mirjana MILIJEVIC |
Bulgaria | Dr Peter RASHKOV |
Croatia | Prof Ana Marija GRANCARIC |
Czech Republic | Dr Kamil MUSILEK |
Finland | Prof Heikki HAARIO |
France | Prof Hasnaa ZIDANI |
fYR Macedonia | Dr Tatjana ATANASOVA – PACHEMSKA |
fYR Macedonia | Dr Beti ANDONOVIK |
Germany | Prof Christian FISCHER |
Germany | Dr Markus SCHWEHM |
Greece | Prof Constantinos SIETTOS |
Iceland | Dr Benjamin Ragnar SVEINBJORNSSON |
Italy | Prof Ezio VENTURINO |
Italy | Prof Vincenzo CAPASSO |
Netherlands | Dr Bob KOOI |
Poland | Dr Urszula SKWARA |
Poland | Dr Dorota MOZYRSKA |
Portugal | Dr Peyman GHAFFARI |
Portugal | Prof Nico STOLLENWERK |
Romania | Prof Sebastian ANITA |
Romania | Prof Andrei HALANAY |
Serbia | Dr Milica KARADŽIĆ |
Spain | Ms Virginia Sanz Sánchez |
United Kingdom | Dr Andrea PARISI |
United Kingdom | ■ Dr Lauren CATOR |
Country | MC Substitute |
---|---|
Belgium | Ms Els VAN DER BURGHT |
Czech Republic | Dr Jitka KUHNOVÁ |
Germany | Prof Thomas GOETZ |
Italy | Prof Giulio MALUCELLI |
Poland | Dr Małgorzata WYRWAS |
Portugal | Dr César MARTINS |
Portugal | Dr Maira AGUIAR |
Romania | Prof Gabriel DIMITRIU |
THE NETWORK AS A WHOLE
This Action consists of 19 academic/research institutes, 5 SMEs and Manufacturing companies/partners, from 8 European countries and 5 COST International Partner-countries, representing a network of expertise in epidemiology, biostatistics, textile & paint-research, nano- and micro-technology, mosquito research, vector-borne diseases and mathematics. It is expected that at least 2 other European countries will join in. One major European company showed interest and is expecting to join in the future. The Action also expects that, as the network grows, more SMEs will cooperate with the Action, due to its interdisciplinary nature.
This will also attract a higher number of Early Career Investigators (ECI). At this initial stage already 11 ECIs are included. This network will tackle the lack of interaction and coordination between sectors of mentioned expertise, to provide new solutions for combating vector-borne diseases. The available knowledge generated by this network will also be beneficial for other sectors within vector-borne diseases research, and will create a positive environment for fruitful collaborations and synergies in this research area.